Literature DB >> 15145326

Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohort.

Yasuko Uchigata1, Keiko Asao, Masato Matsushima, Akiko Sato, Hiroki Yokoyama, Toshika Otani, Tadasu Kasahara, Hiroko Takaike, Maki Okudaira, Junnosuke Miura, Hitomi Takada, Kazuko Muto, Mari Osawa, Nobuo Matsuura, Hiroshi Maruyama, Yasuhiko Iwamoto.   

Abstract

The aim of this study was to compare mortality and incidence of end-stage renal disease (ESRD) in patients with type 1 (insulin-dependent) diabetes who had attended a diabetes center with those who had not. The cohort consisted of a total of 1430 patients diagnosed with Type 1 diabetes at 18 years or younger, and between 1965 and 1979. This population-based cohort in Japan was subdivided into two groups: patients who had visited a large diabetes center in Tokyo (n=162) and those who had not (n=1212). Mortality and incidence of ESRD were compared between the two subgroups as of January 1, 1990. Crude mortality was 1.95 per 1000 person-years (95% CI: 0.49-5.06) for those who had visited the center and 6.05 (4.86-7.41) for those who had not. A multivariate Cox proportional hazard model showed that the patients who had visited the center were three times less likely to die (hazard ratio: 0.31, 95% CI: 0.10-0.98) than those who had not. Crude incidence of ESRD was 1.32 (0.22-4.09) and 5.86 (4.65-7.26) for those who had visited the center and for those who had not, respectively. After adjusting for covariates, the patients who had visited the center were five times less likely to develop ESRD (hazard ratio: 0.19, 0.05-0.78) than those who had not. Education and treatment of type 1 diabetes with an integrated management system under specialists and a multidisciplinary team appears to be associated with a better prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15145326     DOI: 10.1016/j.jdiacomp.2003.10.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  5 in total

1.  Clinical background of Japanese patients with type 1 diabetes mellitus who have received insulin therapy for 50 years or longer.

Authors:  Toshika Otani; Tadasu Kasahara; Junnosuke Miura; Yasuko Uchigata; Tetsuya Babazono
Journal:  Diabetol Int       Date:  2019-04-11

2.  Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics.

Authors:  Deepthi Takkalapelli Rao; Lily Kristine Sunio; Yun-Jia Lo; Ved Vyas Gossain
Journal:  J Diabetes Metab Disord       Date:  2015-04-24

3.  Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey.

Authors:  Toshika Otani; Hiroki Yokoyama; Yasuo Ohashi; Yasuko Uchigata
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-11

Review 4.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

5.  Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years.

Authors:  Toshika Otani; Hiroki Yokoyama; Ko Hanai; Junnosuke Miura; Yasuko Uchigata; Tetsuya Babazono
Journal:  Clin Pediatr Endocrinol       Date:  2019-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.